Login / Signup

Concurrent immunoradiation for HPV-associated oropharyngeal squamous cell carcinoma.

Raj SinghJohn Austin VargoShiyu Song
Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2022)
I-RT was associated with significantly poorer OS vs. C-RT with no benefit compared to RT for HPV-associated OP-SCCs. I-RT is not recommended outside of currently accruing clinical trials.
Keyphrases
  • squamous cell carcinoma
  • clinical trial
  • high grade
  • locally advanced
  • randomized controlled trial
  • radiation therapy
  • study protocol